CSPC Pharmaceutical Drug Shows 'Favorable' Anti-tumor Profile in Study
Published on 06/03/2026 at 11:09 am HKT
MT Newswires
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.890 HKD | -0.58% |
|
-4.44% | -18.27% |
| 08:45pm | CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA | MT |
| 08:26pm | CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China | MT |
Employees
19,700
Sector
Pharmaceuticals
Calendar
06-24 -
Ex-dividend date - 0.15 HKD
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
6.930HKD
Average target price
11.49HKD
Spread / Average Target
+65.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- CSPC Pharmaceutical Drug Shows 'Favorable' Anti-tumor Profile in Study
Select your edition
All financial news and data tailored to specific country editions
